Sarolaner (English Wikipedia)
Analysis of information sources in references of the Wikipedia article "Sarolaner" in English language version.
refsWebsite
Global rank
English rank
1st place
1st place
low place
8,938th place
low place
low place
canada.ca (Global: 1,712th place; English: 1,063rd place)
- "Notice: Prescription Drug List (PDL): Multiple additions [2016-08-09]". Health Canada. 9 August 2016. Retrieved 10 July 2024.
- "Drug and medical device highlights 2018: Helping you maintain and improve your health". Health Canada. 14 October 2020. Archived from the original on 17 April 2024. Retrieved 10 July 2024.
- "Drug and medical device highlights 2019: Helping you maintain and improve your health". Health Canada. 18 November 2020. Retrieved 10 July 2024.
doi.org (Global: 2nd place; English: 2nd place)
- McTier TL, Chubb N, Curtis MP, Hedges L, Inskeep GA, Knauer CS, et al. (May 2016). "Discovery of sarolaner: A novel, orally administered, broad-spectrum, isoxazoline ectoparasiticide for dogs" (PDF). Veterinary Parasitology. 222: 3–11. doi:10.1016/j.vetpar.2016.02.019. PMID 26961590. Archived (PDF) from the original on 4 November 2020. Retrieved 13 March 2022.
dundee.ac.uk (Global: low place; English: 8,938th place)
discovery.dundee.ac.uk
- McTier TL, Chubb N, Curtis MP, Hedges L, Inskeep GA, Knauer CS, et al. (May 2016). "Discovery of sarolaner: A novel, orally administered, broad-spectrum, isoxazoline ectoparasiticide for dogs" (PDF). Veterinary Parasitology. 222: 3–11. doi:10.1016/j.vetpar.2016.02.019. PMID 26961590. Archived (PDF) from the original on 4 November 2020. Retrieved 13 March 2022.
europa.eu (Global: 68th place; English: 117th place)
ema.europa.eu
- "Simparica EPAR". European Medicines Agency. 18 December 2015. Archived from the original on 10 July 2024. Retrieved 13 June 2024.
- "MiPet Easecto EPAR". European Medicines Agency. 23 February 2018. Archived from the original on 10 July 2024. Retrieved 13 June 2024.
- "Simparica Trio EPAR". European Medicines Agency. 14 October 2019. Archived from the original on 15 June 2024. Retrieved 15 June 2024.
- "Stronghold Plus". European Medicines Agency. 9 March 2017. Archived from the original on 10 July 2024. Retrieved 12 December 2022.
fda.gov (Global: 447th place; English: 338th place)
animaldrugsatfda.fda.gov
- "Simparica". U.S. Food and Drug Administration (FDA). Archived from the original on 10 July 2024. Retrieved 12 December 2022.
- "Simparica Trio". U.S. Food and Drug Administration (FDA). Archived from the original on 9 December 2022. Retrieved 12 December 2022.
- "Revolution Plus". U.S. Food and Drug Administration (FDA). Archived from the original on 10 July 2024. Retrieved 12 December 2022.
- fda.gov
fda.gov
- "FDA Approves Simparica Trio, a Combination Drug for Heartworm and Other Parasites". U.S. Food and Drug Administration (FDA). 2 March 2020. Archived from the original on 24 September 2021. Retrieved 26 June 2021.
- "Recent Animal Drug Approvals". U.S. Food and Drug Administration (FDA). 2 December 2024. Archived from the original on 12 September 2019. Retrieved 21 December 2024.
This article incorporates text from this source, which is in the public domain.
nih.gov (Global: 4th place; English: 4th place)
pubmed.ncbi.nlm.nih.gov
- McTier TL, Chubb N, Curtis MP, Hedges L, Inskeep GA, Knauer CS, et al. (May 2016). "Discovery of sarolaner: A novel, orally administered, broad-spectrum, isoxazoline ectoparasiticide for dogs" (PDF). Veterinary Parasitology. 222: 3–11. doi:10.1016/j.vetpar.2016.02.019. PMID 26961590. Archived (PDF) from the original on 4 November 2020. Retrieved 13 March 2022.
vcahospitals.com (Global: low place; English: low place)
- Gollakner R. "Sarolaner". vcahospitals.com. VCA Hospitals. Archived from the original on 27 June 2021. Retrieved 26 June 2021.
web.archive.org (Global: 1st place; English: 1st place)
- "Drug and medical device highlights 2018: Helping you maintain and improve your health". Health Canada. 14 October 2020. Archived from the original on 17 April 2024. Retrieved 10 July 2024.
- "Simparica". U.S. Food and Drug Administration (FDA). Archived from the original on 10 July 2024. Retrieved 12 December 2022.
- "Simparica EPAR". European Medicines Agency. 18 December 2015. Archived from the original on 10 July 2024. Retrieved 13 June 2024.
- "MiPet Easecto EPAR". European Medicines Agency. 23 February 2018. Archived from the original on 10 July 2024. Retrieved 13 June 2024.
- McTier TL, Chubb N, Curtis MP, Hedges L, Inskeep GA, Knauer CS, et al. (May 2016). "Discovery of sarolaner: A novel, orally administered, broad-spectrum, isoxazoline ectoparasiticide for dogs" (PDF). Veterinary Parasitology. 222: 3–11. doi:10.1016/j.vetpar.2016.02.019. PMID 26961590. Archived (PDF) from the original on 4 November 2020. Retrieved 13 March 2022.
- Gollakner R. "Sarolaner". vcahospitals.com. VCA Hospitals. Archived from the original on 27 June 2021. Retrieved 26 June 2021.
- "Simparica Trio". U.S. Food and Drug Administration (FDA). Archived from the original on 9 December 2022. Retrieved 12 December 2022.
- "Simparica Trio EPAR". European Medicines Agency. 14 October 2019. Archived from the original on 15 June 2024. Retrieved 15 June 2024.
- "FDA Approves Simparica Trio, a Combination Drug for Heartworm and Other Parasites". U.S. Food and Drug Administration (FDA). 2 March 2020. Archived from the original on 24 September 2021. Retrieved 26 June 2021.
- "Stronghold Plus". European Medicines Agency. 9 March 2017. Archived from the original on 10 July 2024. Retrieved 12 December 2022.
- "Revolution Plus". U.S. Food and Drug Administration (FDA). Archived from the original on 10 July 2024. Retrieved 12 December 2022.
- "Recent Animal Drug Approvals". U.S. Food and Drug Administration (FDA). 2 December 2024. Archived from the original on 12 September 2019. Retrieved 21 December 2024. This article incorporates text from this source, which is in the public domain.